Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.60 |
| ▸ | HPGD | P15428 | 4/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | AHR | P35869 | 3/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | ACLY | P53396 | 1/20 | 0.34 |
| ▸ | CRHBP | P24387 | 1/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.33 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29720512 | 1.00 | TSHR (0.60) | TSHRHSD17B10HPGDCYP3A4ALDH1A1 | |
| SCHEMBL8820666 | 0.97 | TSHR (0.57) | TSHRHSD17B10HPGDCYP3A4ALDH1A1 | |
| SCHEMBL2215984 | 0.97 | TSHR (0.57) | TSHRHSD17B10HPGDCYP3A4ALDH1A1 | |
| SCHEMBL30733854 | 0.89 | HSD17B10 (0.60) | TSHRHSD17B10HPGDCYP3A4ALDH1A1 | |
| SCHEMBL8070919 | 0.89 | HSD17B10 (0.60) | TSHRHSD17B10HPGDCYP3A4ALDH1A1 | |
| SCHEMBL8640677 | 0.83 | TSHR (0.52) | TSHRHSD17B10HPGDCYP3A4ALDH1A1 | |
| SCHEMBL3850787 | 0.82 | AHR (0.58) | TSHRCYP3A4ALDH1A1AHRCA1 | |
| SCHEMBL48305 | 0.82 | HSD17B10 (0.86) | TSHRHSD17B10HPGDCYP3A4ALDH1A1 | |
| SCHEMBL11595609 | 0.80 | HSD17B10 (0.55) | TSHRHSD17B10HPGDCYP3A4ALDH1A1 | |
| SCHEMBL29663733 | 0.80 | HSD17B10 (0.55) | TSHRHSD17B10HPGDCYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119081639-A | Semitransparent room temperature curing double-component silicone rubber special for beauty treatment rubber and preparation method thereof | 广东聚思新材料科技有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-110105219-B | Method for preparing intermediate for antiviral drug | 张磊 | 2020-04-14 | — | — | CN | claimed |
| CN-110612119-A | Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents | 西雅图儿童医院（DBA西雅图儿童研究所） | 2019-12-24 | — | — | CN | claimed |
| WO-2018148224-A1 | PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS | Seattle Children's Hospital (dba Seattle Children's Research Institute) (US) | 2018-08-16 | — | — | WO | claimed |
| CN-105819618-A | Device for treating suspended matter in sewage through flocculation aeration composite method and removing method thereof | 江苏建筑职业技术学院 | 2016-08-03 | — | — | CN | claimed |
| EP-0233288-A1 | ACARICIDE | EARTH CHEMICAL CO., LTD. (JP) | 1987-08-26 | — | — | EP | claimed |
| US-4388215-A | SYNERGISTIC COMBINATION OF 2-MERCAPTOBENZOTHIAZOLE AND A HALOGENATED PHENOL | SANYO MOKUZAI BOFU KABUSHIKI KAISHA (JP) | 1983-06-14 | — | — | US | claimed |
| EP-0004660-B1 | PROCESS FOR PREPARING 2,5-DICHLORO-4-CYANOPHENOL | CELAMERCK GmbH & Co. KG (DE) | 1981-04-29 | — | — | EP | claimed |
| EP-0004660-A1 | Process for preparing 2,5-dichloro-4-cyanophenol | CELAMERCK GmbH & Co. KG (DE) | 1979-10-17 | — | — | EP | claimed |
| US-4067913-A | Process for the production of 2,5-dichloro-4-bromophenol | VELSICOL CHEMICAL CORPORATION (US) | 1978-01-10 | — | — | US | claimed |
| JP-61129102-A | — | — | None | — | — | JP | disclosed |
| JP-1221301-A | — | — | None | — | — | JP | disclosed |
| JP-4005201-A | — | — | None | — | — | JP | disclosed |
| JP-62258332-A | — | — | None | — | — | JP | disclosed |
| US-20260092064-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | OPPILAN PHARMA LTD. (GB) | 2026-04-02 | — | — | US | disclosed |
| US-4000270-A | INSECTIDES, ACARICIDES, NEMATOCIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-12-28 | — | — | US | disclosed |
| US-3969404-A | Process for preparation of 2-methoxy-3,6-dichloro-benzoic acid | CELAMERCK GMBH & CO. KG (DT) | 1976-07-13 | — | — | US | disclosed |
| US-3969403-A | Process for preparation of 2-methoxy-3,6-dichloro-benzoic acid | CELAMERCK GMBH & CO. KG (DT) | 1976-07-13 | — | — | US | disclosed |
| US-3954919-A | INSECTICIDES, MITICIDES, NEMATOCIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-04 | — | — | US | disclosed |
| US-3728403-A | PROCESS FOR PREPARING 2,5-DICHLORO-4-BROMOPHENOL | VELSICOL CHEMICAL CORP | 1973-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092064-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | XDH, MALT1, CBR1 | TSHR 226/4885HSD17B10 464/4885HPGD 2000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.